It was February 22nd when the virologist Giorgio Palù, confirmed as president of the new Aifa...
Read more“It takes years for a diagnosis of severe asthma and just as many for treatment. The...
Read more(Adnkronos) - A survey presented by GSK on the eve of Shingles Awareness Week highlights a...
Read more“Today is an important day for us, precisely in the respiratory sector, one of the historic...
Read moreWith a press conference held today in Milan, the global biopharmaceutical company AstraZeneca announced that the...
Read more“Tezepelumab is a biological drug that acts upstream of the inflammatory cascade, impacting alarmin, one of...
Read more"Tezepelumab is the first anti-Tslp biologic approved in our country. This confirms AstraZeneca's commitment in the...
Read more“The use of biologics has radically changed the treatment of patients with severe asthma. Thanks to...
Read more"The advantage of tezepelumab is that it acts on an upstream target in the pathophysiology of...
Read moreIn collaboration with: Dr. De Masi Modern psychology deals with a wide range of disorders, and...
Read more© Ruetir 2024. All Rights Reserved.